The effectiveness of thymectomy on seronegative generalized myasthenia gravis: Comparing with seropositive cases

Acta Neurologica Scandinavica

Volumn 115, Issue 3, 2007, Pages 181-184

  Yuan, H K ^a   Huang, B S ^a   Kung, S Y ^a   Kao, K P ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acetylcholine receptor antibody; AChRAb; Immunosuppression; Myasthenia gravis; Non thymomatous; Seronegative; Thymectomy

Indexed keywords

HUMAN IMMUNOGLOBULIN; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MYASTHENIA GRAVIS; ONSET AGE; PATHOLOGY; PLASMAPHERESIS; PREOPERATIVE CARE; PROBABILITY; REMISSION; RETROSPECTIVE STUDY; SERODIAGNOSIS; TAIWAN; THYMECTOMY; THYMUS HYPERPLASIA;

ADULT; ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYASTHENIA GRAVIS; RECEPTORS, NICOTINIC; RETROSPECTIVE STUDIES; TAIWAN; THYMECTOMY; TREATMENT OUTCOME;

EID: 33846859099     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00733.x     Document Type: Article

References (22)

1. LINDSTROM JM, SEYBOLD ME, LENNON VA et al. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-9.
2. GRONSETH GS, BAROHN RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:7-15.
3. EVOLI A, BATOCCHI AP, TONALI P. A practical guide to the recognition and management of myasthenia gravis. Drugs, 1996;52:662-70.
4. DETTERBECK FC, SCOTT WW, HOWARD JF JR et al. One hundred consecutive thymectomies for myasthenia gravis. Ann Thorac Surg, 1996;62:242-5.
5. DRACHMAN DB. Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
6. SANDERS DBMD, IAN ANDREWS PF, HOWARD JFJMD et al. Seronegative myasthenia gravis. Neurology 1997;48:40S-5S.
7. MOSSMAN S, VINCENT A, NEWSOM-DAVIS J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986;1:116-9.
8. GUILLERMO GR, TELLEZ-ZENTENO JF, WEDER-CISNEROS N et al. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients. Acta Neurol Scand 2004;109:217-21.
9. EVOLI A, TONALI PA, PADUA L et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11.
10. SOLIVEN BC, LANGE DJ, PENN AS et al. Seronegative myasthenia gravis. Neurology 1988;38:514-7.
11. VINCENT A, NEWSOM-DAVIS J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-52.
12. HUANG CS, HSU HS, HUANG BS et al. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis. Acta Neurol Scand 2005;112:108-14.
13. JARETZKI A, III., BAROHN RJ, ERNSTOFF RM et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 2000;70:327-34.
14. PALACE J, VINCENT A, BEESON D. Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol 2001;14:583-9.
15. BEGHI E, ANTOZZI C, BATOCCHI AP et al. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 1991;106:213-20.
16. MANTEGAZZA R, BEGHI E, PAREYSON D et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990;237:339-44.
17. ROMI F, AARLI JA, GILHUS NE. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 2005;12:413-8.
18. BUSCH C, MACHENS A, PICHLMEIER U et al. Long-term outcome and quality of life after thymectomy for myasthenia gravis. Ann Surg 1996;224:225-32.
19. FRIST WH, THIRUMALAI S, DOEHRING CB et al. Thymectomy for the myasthenia gravis patient: factors influencing outcome. Ann Thorac Surg 1994;57:334-8.
20. LEITE MI, STROBEL P, JONES M et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 2005;57:444-8.
21. LAURIOLA L, RANELLETTI F, MAGGIANO N et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005;64:536-8.
22. YEH JH, CHEN WH, CHIU HC. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 2004;62:2131-2.